Cited by 38Transplantation: Methods and OutcomesIntensive Care Unit Cognitive DisordersCancer-related cognitive impairment studies

Changes in neurocognitive functioning following lung transplantation

Open access
Hoffman, B.M., Blumenthal, J.A., Carney, R.C., O’Hayer, C.V.F., Freedland, K., Smith, P.J., Babyak, M.A., Davis, R.D. +3 more·2012·American Journal of Transplantation

Abstract

Although neurocognitive impairment is relatively common among patients with advanced lung disease, little is known regarding changes in neurocognition following lung transplantation. We therefore administered 10 tests of neurocognitive functioning before and 6 months following lung transplantation and sought to identify predictors of change. Among the 49 study participants, native diseases included chronic obstructive pulmonary disease (n = 22), cystic fibrosis (n = 12), nonfibrotic diseases (n = 11) and other (n = 4). Although composite measures of executive function and verbal memory scores were generally within normal limits both before and after lung transplantation, verbal memory performance was slightly better posttransplant compared to baseline (p < 0.0001). Executive function scores improved in younger patients but worsened in older patients (p = 0.03). A minority subset of patients (29%) exhibited significant cognitive decline (i.e. >1 standard deviations on at least 20% of tests) from baseline to posttransplant. Patients who declined were older (p < 0.004) and tended to be less educated (p = 0.07). Lung transplantation, like cardiac revascularization procedures, appears to be associated with cognitive decline in a subset of older patients, which could impact daily functioning posttransplant.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-6143.2012.04072.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other forms of cognitive dysfunction among individuals with advanced pulmonary disease may be amplified by hypoxemia or polypharmacy, and may improve post-transplant in some cases.

    “Other forms of cognitive dysfunction among individuals with advanced pulmonary disease may be amplified by hypoxemia or polypharmacy, and may improve post-transplant in some cases.(94–99)”

    From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [99]

    The introductory passage (page unavailable) identifies hypoxemia as a possible contributor to neurocognitive impairment in end-stage lung disease. The Conclusions (page unavailable) report that neurocognitive functioning improved in some cases after transplantation. The paper discusses medication side effects as a possible contributor to post-transplant decline, but does not identify polypharmacy as a contributor to cognitive dysfunction in advanced pulmonary disease. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoffman, B. M., Blumenthal, J. A., Carney, R. C., O’Hayer, C. V. F., Freedland, K., Smith, P. J., Babyak, M. A., Davis, R. D., Mathew, J. P., Martinu, T., & Palmer, S.
Affiliations
  • Duke University (US)
  • Duke Medical Center (US)
  • Washington University in St. Louis (US)
Corresponding author
Hoffman, B.M.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2012-09
Volume
12
Issue
9
Pages
2519-2525
ISSN
1600-6135 (ISSN-L)
OpenAlex
W1874988841
Cited by
38
References
22
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 1
FWCI
1.96
Type
journal article
Language
en
Open access
Locations
  • American Journal of Transplantation (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Health and Human Services
  • Health Resources and Services Administration
  • National Heart, Lung, and Blood Institute (R01HL065503, HL 065503-06A1, HL65503-01)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cancer-related cognitive impairment studies
Keywords
lung transplantation, neurocognitive function, cognitive decline, executive function, verbal memory, chronic obstructive pulmonary disease, cystic fibrosis, age as predictor, educational attainment, advanced lung disease
MeSH terms
Adult, Cognition, Female, Humans, Lung Diseases, Male, Lung Transplantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review